Shareholders of drugmaker Perrigo shut the door on Mylan and its $26B, hostile takeover bidStaff WriterColumbus CEONEW YORK (AP) — Shareholders of drugmaker Perrigo shut the door on Mylan and its $26B, hostile takeover bid.